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ABSTRACT
Background: Almost 25% of all new cases of
tuberculosis (TB) worldwide are in India, where drug
resistance and low quality of care remain key
challenges.
Methods: We conducted an observational, cross-
sectional study of healthcare providers’ knowledge of
diagnosis and treatment of TB in rural Bihar, India,
from June to September 2012. Using data from
vignette-based interviews with 395 most commonly
visited healthcare providers in study areas, we scored
providers’ knowledge and used multivariable regression
models to examine their relationship to providers’
characteristics.
Findings: 80% of 395 providers had no formal
medical qualifications. Overall, providers
demonstrated low levels of knowledge: 64.9% (95%
CI 59.8% to 69.8%) diagnosed correctly, and 21.7%
(CI 16.8% to 27.1%) recommended correct
treatment. Providers seldom asked diagnostic
questions such as fever (31.4%, CI 26.8% to 36.2%)
and bloody sputum (11.1%, CI 8.2% to 14.7%), or
results from sputum microscopy (20.0%, CI: 16.2%
to 24.3%). After controlling for whether providers
treat TB, MBBS providers were not significantly
different, from unqualified providers or those with
alternative medical qualifications, on knowledge score
or offering correct treatment. MBBS providers were,
however, more likely to recommend referrals relative
to complementary medicine and unqualified
providers (23.2 and 37.7 percentage points,
respectively).
Interpretation: Healthcare providers in rural areas in
Bihar, India, have low levels of knowledge regarding
TB diagnosis and treatment. Our findings highlight
the need for policies to improve training, incentives,
task shifting and regulation to improve knowledge
and performance of existing providers. Further,
more research is needed on the incentives providers
face and the role of information on quality to help
patients select providers who offer higher quality
care.
Key questions
What is already known about this topic?
▸ Tuberculosis (TB) drug resistance is a major
public health challenge globally and in India; a
key contributing factor is poor knowledge of TB
diagnosis and treatment among providers.
▸ Evidence from systematic reviews shows long
diagnostic delays for TB, with patients frequently
switching providers—suggesting they do not
receive appropriate care that they are satisfied
with.
▸ Recent studies in India have also demonstrated
gaps between what providers know and what
they do in clinical practice—the know-do gap.
What are the new findings?
▸ This study measures providers’ knowledge of
diagnosis and treatment of TB, using a sampling
method designed to estimate competence of
providers who are most commonly visited by
households in study areas.
▸ In addition to finding low levels of provider com-
petence in diagnosis and treatment of TB, we
also find evidence suggesting that, among all
providers who report that they treat TB cases,
there is no significant association between
having formal medical training and provider com-
petence. Providers with medical training were not
more likely to diagnose or treat TB correctly com-
pared with those without formal training.
▸ Our analysis also demonstrates the severe infor-
mation asymmetry problems in the healthcare
market because of which patients in these set-
tings are unable to rely on common signals of
quality such as medical degrees or experience to
infer provider competence.
Recommendations for policy
▸ Our results highlight the need for policies to
improve training, incentives, task shifting and
regulation to improve knowledge and performance
of existing providers in the healthcare system.
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INTRODUCTION
The scale of India’s tuberculosis (TB) burden looms
large, contributing almost a quarter of the 9.6 million
cases worldwide.1 Bihar, one of India’s largest and
poorest states, bears a substantial share of India’s TB
burden, as active TB disease is associated with poverty.2–4
With over 100 million inhabitants and a per-capita
annual income of $502i in 2011, less than half of India’s
national average, Bihar’s healthcare system registered
almost 68 000 new TB patients in 2015 alone.5 6
A major challenge to achieving improved outcomes in
Bihar is the generally poor quality of medical care avail-
able to patients in rural areas.7 In the public sector, lack
of availability of trained providers and absenteeism
among medical care providers is a key limitation—as
high as 67% in primary health centres among doctors
and 52% among nurses.8 9 Not surprisingly then, over
90% of the healthcare used by households (outpatient
care) in rural Bihar is provided by the private sector, of
which 70% is from informal sector providers.10 The net
result of widespread absenteeism in the formal public
sector, untrained informal sector providers and low
levels of provider effort is the alarmingly low quality of
care provided to patients.
Active TB disease is treatable, and multidrug resistance
potentially avoidable, provided that cases can be cor-
rectly diagnosed and appropriate treatment regimens
are administered for adequate periods of time. However,
systematic reviews from India have shown long diagnostic
delays with patients frequently switching providers,11 and
have also shown poor quality of TB care in India.12
Previous studies of rural patients in Bihar treated for TB
using DOTS (Directly Observed Treatment, Short
course) in the public sector show high rates of drop-out
and symptom persistence, despite completing treat-
ment.13 Another study that sampled 371 174 individuals
in 30 districts across India shows that nearly half of those
with TB who sought care did so in private sector and
non-DOTS settings.14 Yet, the potential for higher
quality TB diagnosis and treatment as represented by
the limits of provider knowledge remains ill charac-
terised in settings like Bihar, especially among private
sector providers who are the first point of medical
contact for most rural patients. There are no statewide
efforts to engage the informal private sector in TB
control.
This paper contributes to the literature on quality of
care in rural areas in developing countries, focusing on
the diagnosis and treatment of TB—a chronic, commu-
nicable disease of global significance.1 We estimate the
knowledge of healthcare providers in rural Bihar, India,
in terms of providing a correct diagnosis of TB and pre-
scribing the appropriate treatment when interviewed
using clinical vignettes. We also analyse how healthcare
provider characteristics that are observable to patients
predict the probability of a correct diagnosis and treat-
ment for the vignettes. Findings from these analyses
have important public health and policy implications for
improving low levels of provider knowledge and increas-
ing the quality of TB diagnosis and treatment.
METHODS
Setting
We analyse data from provider quality assessments
undertaken as part of baseline surveys conducted for the
Bihar Evaluation of Social Franchising and Telemedicine
(BEST) project—an evaluation of a large telemedicine
programme funded by the Bill and Melinda Gates
Foundation in Bihar.15
Sampling method
The provider surveys and quality assessments were con-
ducted in 80 randomly selected clusters (out of 360
rural clusters) in the study, representing rural areas from
11 districts. Clusters in the study were defined to repre-
sent market catchment areas with a population of
∼20 000 as described in Mohanan et al.16 The objective
of the provider surveys was to assess the knowledge of
the providers who deliver care to households surveyed at
baseline. In each cluster, data from interviews with 64
randomly selected households were used to generate a
list of all providers visited in the past 6 months, regard-
less of medical training of the providers. The number of
households was chosen based on power calculations to
estimate the impact of the programme on population
health outcomes.16 We selected the five most frequently
visited providers as reported by the 64 randomly selected
households in each cluster for inclusion in the present
study, in order to have 90% power to detect a 20%
improvement in quality of care provided. The total
number of providers in the study areas ranged between
6 and 70;16 the current study focuses on the 5 most com-
monly visited providers in these clusters. Since some
clusters had fewer than 5 providers, our final sample
includes 395 providers. We administered surveys as well
as a series of clinical vignettes to each sampled provider,
including a vignette for a case of suspected pulmonary
TB. The BEST study protocol was approved by Duke
University (29755) and India’s Health Ministry Steering
Committee (number 12/2008/30-HMSC/4).
Data collection instruments
We use data from the provider surveys and provider
responses to vignettes to assess the quality of care avail-
able for TB patients. Trained interviewers first adminis-
tered a detailed structured survey to each sampled
provider. The survey collected information on provider
characteristics, such as age, education, medical qualifica-
tions, experience, types of clinical activities in practice,
types of illnesses treated and infrastructure in the facility
in which they practice.iUsing the average 2011 exchange rate of INR 49.12 to US$1.
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To measure provider knowledge, we analyse data from
clinical vignettes. The vignette method involves present-
ing a hypothetical case to the provider in an interview
setting with two interviewers, one reading out scripted
answers to the provider’s questions and the other
recording all of the provider’s responses to the vignette.
The case intends to represent a new pulmonary TB
patient, who is visiting a healthcare provider for the first
time, with productive cough of more than 2 weeks,
accompanied by chest pain, haemoptysis, loss of appe-
tite, weight loss, night sweats and fever.
The TB vignette starts with the interviewer telling the
provider to assume that a man aged 40 years visits the
provider and that he will comply with all tests and medi-
cations that the provider might recommend and will
return if required. The patient reports, “Doctor, I have
been suffering from fever, cough and weakness, and I
have been losing weight.” The provider then proceeds to
ask history questions (eg, ‘Do you have fever with chills?’)
and the interviewer reads out the scripted responses
(‘No’). If the provider says she would examine the
patient and check his pulse, respiratory rate or auscultate
his chest, the interviewer will read out the appropriate
responses (‘80 bpm’, ‘20 breaths/minute’, ‘normal breath
sounds’, respectively). Similarly, the vignettes also provide
results on tests that the provider might recommend—if
specific blood tests were recommended, the enumerators
would read out test results. An X-ray was provided on
request showing opacity in the right apex. After pilot
testing, and based on previous studies conducted in a
range of settings,17 as well as inputs from local clinicians,
the vignettes were designed to include clinically relevant
information as well as information that were commonly
asked for by providers for social or cultural reasons (such
as marital status or number of children). (See vignette
modules included in online supplementary appendix).
The vignette responses provide information about
whether the doctor is able to ask the most clinically
relevant questions, to establish the correct diagnosis
and also detailed information about the investigations
recommended and treatment prescribed. Analyses of
the providers’ characteristics in relation to their per-
formance on the vignettes (ie, correctly diagnosing
and offering appropriate treatment) form the core of
our analysis.
Statistical analysis
Descriptive statistics for provider characteristics were
computed to compare groups of providers with and
without medical qualifications. Differences between
these two groups were tested using unpaired two-tailed
t-tests and χ2 tests of proportions, with SEs adjusted for
the study design.
We assessed providers’ performance on vignettes
based on: (1) correct diagnosis; (2) correct treatment
and (3) recommendation of a referral to another pro-
vider or hospital. Of note, a large share of providers
reported not seeing or treating TB patients: 24.6% of
those with medical qualifications and 67.2% of those
without. While it is possible to analyse provider TB
vignette performance only for those reporting seeing
and treating TB patients, we chose instead to analyse all
providers based on the following rationale. Since TB is
endemic in rural Bihar, patients may present with symp-
toms of their illness even to providers who do not claim
to treat TB since patients will not know that they are suf-
fering from TB when they visit the provider. In such a
situation, if the provider does not recognise the symp-
toms, and ask the right diagnostic questions or perform
the minimum necessary examinations, TB patients
would still receive delayed TB diagnosis and poor quality
healthcare. We include providers with and without
formal qualifications. Practitioners with little to no
formal training provide most healthcare in rural areas in
India, and previous studies on quality of care in rural
India report that the quality of care provided by practi-
tioners with formal qualifications is also poor .ii 7 18–21
Hence, our analysis of provider performance on vign-
ettes includes all providers in our sample. We also
include analogous analyses and findings after restricting
to providers who claim to treat TB in the online
supplementary appendix.
For diagnosis and treatment, we concentrated our ana-
lyses on three aspects: (1) diagnostic process; (2) provid-
ing a correct diagnosis and (3) whether or not the
correct treatment was prescribed. We assessed the diag-
nostic process each provider stated that he/she would
undertake (ie, the questions, examinations and tests
used to form a diagnosis) relative to standard diagnostic
procedures to measure ‘knowledge’. We summarised
provider knowledge using Item Response Theory (IRT)
to calculate a knowledge score for each provider using
previously developed methods.17 The IRT methodology
is a model-based measurement used to describe the rela-
tion between how the provider responds to a set of ques-
tions and the level of the ‘latent variable’ (knowledge)
being measured by the scale. It is widely used in settings
to assess items in questionnaires where participants are
scored on multiple items to recover an underlying latent
trait or ability. In the context of our paper, a correct
response to an item is obtained every time a provider
asks a key diagnostic question (such as duration of
cough), or for results of diagnostic tests (such as sputum
smear) or performs a relevant examination (listed in
table 2), and our latent variable or trait is the provider’s
overall knowledge. We use a three-parametric logistic
(3PL) model to construct our knowledge index following
Das and Hammer.17 Regardless of diagnostic process, we
assessed whether each provider correctly stated a diagno-
sis of the case in the vignette as being TB.
iiBased on evidence that informal and formally qualified doctors
provide low quality of care, we examine provider characteristics to
understand if other factors such as experience, qualifications or
volume are correlated with provider quality.
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In identifying the appropriate TB treatment, we fol-
lowed the WHO 2010 guidelines and WHO’s 2014
Standards for TB Care in India.22 The WHO treatment
guidelines state that the treatment of new TB cases
include 6 months of rifampicin as part of a multidrug
regimen (2HRZE+4 HR).iii However, since our investiga-
tors were unable to collect information on duration of
each of the prescribed drugs consistently, with some pro-
viders using generic pharmaceutical names of drugs and
others using brand names, we employ a broader defin-
ition of ‘correct’ treatment. We defined correct treat-
ment to include all prescriptions that included 6 months
of rifampicin as part of a multidrug treatment that also
included any duration of isoniazid.
We examined how a provider’s observable character-
istics are associated with their knowledge using multivari-
able linear regression models because these
characteristics are the features that are available to
patients to choose between providers. We also examined
how knowledge along with a provider’s observable
characteristics related to the probability of making a
correct diagnosis, providing correct treatment and
making a referral using multivariable probit regression
models.iv Further, we conducted analyses where we
restricted the assessment of correct treatment provision
only to those providers who offered any treatment.
All regression models controlled for the age of the
provider, years of experience and medical qualification.
Additionally, in separate specifications, we controlled for
the type of medicine practiced, the number of working
hours per week, average patient caseload per day,
whether providers engaged in public events like running
medical camps, whether the clinic was public or private,
whether provider claimed to treat TB, sold medicines at
the clinic, infrastructure index and average fee charged
by provider. All analyses adjusted SEs for survey design
by clustering at the level of a cluster in our study.v
RESULTS
Provider characteristics
Of the 395 providers most commonly visited by repre-
sentative households in our study areas and interviewed
in our study, 79.5% (314) did not have any formal
medical qualifications. Among those with medical quali-
fications, less than half (35) had MBBS (Bachelor of
Medicine, Bachelor of Surgery—the equivalent of MD in
the USA) degrees or higher, while the remaining 46 had
degrees or diplomas in Ayurveda, Homeopathy or
Unani systems of medicine (BAMS/BHMS/BUMS),23
hereafter abbreviated as BA/H/UMS. Among the 314
providers without formal qualifications, 20.7% (65 out of
314) had some training such as pharmacist or registered
medical practitioner (RMP); a small fraction reported
informal trainingvi where they had worked with other
doctors in the past, while the vast majority (228) had no
formal or informal medical qualification, as seen in
figure 1.
Table 1 describes provider characteristics, among
those with and without medical qualifications. While
providers with formal qualifications have comparable
years of experience as those without qualifications as
well as comparable levels of ownership of the facilities
that they practice in, they vary significantly in the range
of services they provide. MBBS providers report longer
working hours per week, higher participation in camps
and significantly lower rates of providing treatment as
part of their consultation and selling drugs than provi-
ders with training in other systems and those without
training. In rural settings such as the one where this
study was conducted, providers frequently carry their
own stock of medicines and offer medication (treat-
ment) as part of the consultation and charge a com-
bined fee. We recorded this characteristic of the
provider/facility as ‘administering treatment’ in the
survey (90.8% among the unqualified and 76.1% among
the BA/H/UMS group compared with 57.1% among
MBBS providers). Some providers sell drugs separately
as well (53.2% among the unqualified and 41.3%
among the BA/H/UMS group compared with 8.6%
among MBBS providers). Providers with MBBS training
work in clinics with higher levels of infrastructure and
also command fees that are almost twice as high as BA/
H/UMS providers and over three times as high as those
without formal medical qualifications.
When asked whether they provide treatment for TB,
88.6% of MBBS providers reported treating patients, as
did 65.2% of BA/H/UMS providers and 32.8% of those
without qualifications. While it is tempting to conclude
that most providers in the sample—especially those
without medical qualifications—do not manage TB,
such a conclusion would miss a critical point that
patients often do not know what their underlying illness
is, at least in the early stages of the care-seeking pathway.
Patients experience symptoms and seek care from provi-
ders whom they frequently visit.11 24–27 The provider
then has to diagnose the condition, and decide whether
to treat the patient or refer them to a hospital. If provi-
ders incorrectly diagnose TB as another condition, they
iiiThis recommended treatment for new TB cases (fourth edition
published in 2010) has been in place at least since the publication of
the third edition of the WHO tuberculosis treatment guidelines in
2003.
ivEvidence from recent studies from India and other developing
countries shows that providers with qualifications and those without
qualifications provide care that is of very low quality.17 Hence, our
analysis of quality and provider characteristics helps understand if
there are other observable provider characteristics such as age,
experience and patient volume that might serve as useful signals of
quality to patients.
vAll analyses were conducted in STATAV.14.0.
viWe do not have information on whether informal providers have had
any TB training, but since the TB programme in India is run primarily
through the formal public sector, we do not expect that these
providers would have received training.
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Figure 1 Distribution of
providers by qualification.
Table 1 Providers characteristics according to medical education
Variables [1] MBBS [2] BA/H/UMS [3] Other [4] DIFF 1–2 [5] DIFF 1–3
Age (years) 45.7 (42.2 to 49.2) 46.8 (43.6 to 50) 43.5 (42.2 to 44.7) −1.1 2.2
Education >high School (%) 100 (– to –) 97.8 (93.6 to 102.1) 70.7 (65.7 to 75.7) 2.2 29.30***
Has ever used a computer (%) 62.9 (46.6 to 79.1) 30.4 (17 to 43.9) 12.4 (8.8 to 16.1) 32.42*** 50.44***
Experience (years) 18.5 (15 to 22.1) 19 (16 to 21.9) 18.2 (17.1 to 19.4) −0.4 0.3
Average patient caseload (day) 29.3 (23.5 to 35.1) 17.1 (15.6 to 18.6) 17.2 (16.5 to 18) 12.17*** 12.06***
Working hours (per week) 61.8 (56.3 to 67.4) 52.2 (47.2 to 57.2) 48.3 (46.4 to 50.3) 9.61** 13.51***
Run camps (%) 40 (23.5 to 56.5) 6.5 (−0.7 to 13.7) 4.5 (2.2 to 6.7) 33.48*** 35.54***
Public health facility (%) 22.9 (8.7 to 37) 2.2 (−2.1 to 6.4) 0.3 (−0.3 to 0.9) 20.68*** 22.54***
Infrastructure Index 3.1 (2 to 4.3) 0.2 (−0.3 to 0.7) −0.4 (−0.5 to −0.3) 2.92*** 3.53***
Consultation fee (Rs) 64.2 (44.8 to 83.6) 38.6 (26.4 to 50.9) 15.5 (13.3 to 17.6) 25.60** 48.75***
Task (% of providers)
Consultation with patients 100 (– to –) 100 (– to –) 99.7 (99.1 to 100.3) 0.0 0.3
Administering treatment 57.1 (40.5 to 73.8) 76.1 (63.6 to 88.5) 90.8 (87.6 to 94) – –33.62***
Selling drugs 8.6 (−0.8 to 18) 41.3 (26.9 to 55.7) 53.2 (47.7 to 58.7) –32.73*** –44.61***
Laboratory-related duties 17.1 (4.5 to 29.8) 6.5 (−0.7 to 13.7) 3.8 (1.7 to 5.9) 10.6 13.3
Administrative duties 48.6 (31.8 to 65.4) 71.7 (58.6 to 84.9) 61.8 (56.4 to 67.2) –23.17** −13.2
Ownership 51.4 (34.6 to 68.2) 76.1 (63.6 to 88.5) 72 (67 to 77) –24.66** –20.55**
Type of medicine practiced (%)
Allopathic 94.3 (86.5 to 100) 89.1 (80 to 98.2) 91.4 (88.3 to 94.5) 5.2 2.9
Homeopathic/Ayurvedic 20 (6.6 to 33.4) 63 (48.9 to 77.1) 32.8 (27.6 to 38) –43.04*** −12.8
Type of diseases treated (%)
Tuberculosis 88.6 (77.9 to 99.3) 65.2 (51.3 to 79.1) 32.8 (27.6 to 38) 23.35*** 55.77***
VL 2.9 (−2.7 to 8.5) 4.3 (−1.6 to 10.3) 1.9 (0.4 to 3.4) −1.5 1.0
Observations 35 46 314
Columns 1–3 report mean (95% CI) and columns 4 and 5 report differences. BA/H/UMS includes BAMS, BUMS and BHMS degrees as well as
Diploma in Ayurvedic and some others MD degrees. Providers classified as ‘Other’ includes all providers with NO medical training or those with
coursework related in some way to medicine such as pharmacist or informal training. The infrastructure index was computed according to the
following variables: electricity, power backup, number of consulting rooms, number of bed for day observation, provision of tests, provision of
X-rays and computer system.
Asterisks represent statistically significant differences, with ***p<0.01, **p<0.05, *p<0.1. Source: Providers Interview.
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Table 2 Fraction of providers who asked or performed key diagnostic questions and examinations, diagnosis and treatment and average competence score
All providers MBBS [1] BA/H/U/MS [2] Other [3] DIFF 1–2 DIFF 1–3
Questions and examinations
Since when has he had the fever 48.9 (43.8 to 53.9) 51.4 (32.7 to 70.1) 47.8 (33.1 to 62.5) 48.7 (42.7 to 54.7) 3.6 2.7
Fever with chills 31.4 (26.8 to 36.2) 31.4 (16 to 46.9) 32.6 (18.6 to 46.6) 31.2 (25.5 to 37.0) −1.2 0.2
Is fever continuous 33.4 (28.8 to 38.3) 34.3 (16.5 to 52.1) 39.1 (23.5 to 54.8) 32.5 (26.8 to 38.2) −4.8 1.8
Are there any night sweats present 6.1 (3.9 to 8.9) 11.4 (2.2 to 20.6) 6.5 (−0.5 to 13.6) 5.4 (2.9 to 7.9) 4.9 6.0
Cough since when 32.2 (27.6 to 37) 37.1 (22.7 to 51.5) 37.0 (20 to 53.9) 30.9 (24.9 to 36.9) 0.2 6.3
Pain in the chest 13.7 (10.4 to 17.5) 20.0 (5.1 to 34.9) 21.7 (9.5 to 34) 11.8 (8.2 to 15.4) −1.7 8.2
Is there sputum 24.6 (20.4 to 29.1) 34.3 (20.2 to 48.4) 23.9 (10.4 to 37.4) 23.6 (19.0 to 28.2) 10.4 10.7
How is the sputum 24.6 (20.4 to 29.1) 37.1 (20 to 54.3) 23.9 (9.7 to 38.1) 23.2 (18.8 to 27.7) 13.2 13.9
Blood in the sputum 11.1 (8.2 to 14.7) 14.3 (0.7 to 27.9) 13.0 (3.3 to 22.8) 10.5 (7.3 to 13.7) 1.2 3.8
How much blood in the sputum 10.9 (8.0 to 14.4) 8.6 (−0.4 to 17.6) 10.9 (1.4 to 20.3) 11.1 (7.4 to 14.8) −2.3 −2.6
Have you been eating less 13.2 (10 to 16.9) 28.6 (12.3 to 44.8) 23.9 (10.8 to 37.1) 9.9 (6.3 to 13.4) 4.7 18.7**
Have you visited other doctors before coming here 15.9 (12.5 to 19.9) 20.0 (4.2 to 35.8) 8.7 (0.2 to 17.2) 16.6 (11.7 to 21.4) 11.3 3.4
Weight 10.6 (7.8 to 14.1) 25.7 (8.5 to 43) 13.0 (2.8 to 23.3) 8.6 (5.2 to 12.0) 12.7 17.1*
Temperature 16.7 (13.2 to 20.8) 20.0 (7.1 to 32.9) 13.0 (3.0 to 23.1) 16.9 (11.8 to 22.0) 7.0 3.1
Blood for tlc/dlc 32.4 (27.8 to 37.3) 45.7 (27.3 to 64.1) 28.3 (14.8 to 41.7) 31.5 (25.2 to 37.8) 17.5 14.2
Blood test hb 15.9 (12.5 to 19.9) 34.3 (18.5 to 50) 10.9 (1.2 to 20.5) 14.6 (10.0 to 19.3) 23.4** 19.6**
Blood for fasting ESR (erythrocytic sedimentation rate) 32.4 (27.8 to 37.3) 37.1 (20.3 to 54) 26.1 (12.6 to 39.6) 32.8 (26.1 to 39.5) 11.1 4.3
Mantaux tuberculin skin test 12.7 (9.5 to 16.3) 17.1 (3.5 to 30.8) 13.0 (2.8 to 23.3) 12.1 (8.4 to 15.8) 4.1 5.0
Sputum for AFB (acid-fast bacilli) 20.0 (16.2 to 24.3) 54.3 (35.6 to 73) 15.2 (4.5 to 26.0) 16.9 (12.4 to 21.3) 39.1*** 37.4***
Chest X-ray 31.9 (27.3 to 36.7) 57.1 (38.2 to 76.1) 28.3 (13.6 to 42.9) 29.6 (23.9 to 35.3) 28.9** 27.5***
TB test 2.3 (1.0 to 4.3) 2.9 (−2.8 to 8.5) 4.3 (−1.7 to 10.4) 1.9 (0.4 to 3.4) −1.5 1.0
Diagnosis
Gave any diagnosis 92.4 (89.3 to 94.8) 97.1 (91.3 to 103) 95.7 (89.4 to 101.9) 91.4 (88.3 to 94.5) 1.5 5.7*
Correct diagnosis 60.0 (55.0 to 64.9) 91.4 (81.8 to 101) 73.9 (60.8 to 87) 54.5 (48.8 to 60.1) 17.5** 37.0***
Correct diagnosis, if any 64.9 (59.8 to 69.8) 94.1 (86.1 to 102.2) 77.3 (64.4 to 90.2) 59.6 (53.6 to 65.6) 16.8** 34.5***
Treatment
Gave any treatment 66.6 (61.7 to 71.2) 82.9 (71.0 to 94.8) 80.4 (68.1 to 92.8) 62.7 (57.2 to 68.3) 2.4 20.1***
Correct treatment 14.4 (11.1 to 18.3) 45.7 (26.0 to 65.4) 19.6 (8.6 to 30.6) 10.2 (6.8 to 13.6) 26.2** 35.5***
Correct treatment, if any 21.7 (16.8 to 27.1) 55.2 (33.4 to 76.9) 24.3 (11.2 to 37.5) 16.2 (11.1 to 21.4) 30.9** 38.9***
Others
Recommend referral 48.9 (43.8 to 53.9) 77.1 (63.3 to 91.0) 63.0 (48.8 to 77.3) 43.6 (37.4 to 49.9) 14.1 33.5***
Knowledge score −1.0 (−1.2 to −0.73) 0.0 (−0.6 to 0.6) −1.3 (−2.1 to −0.45) −1.0 (−1.3 to −0.7) 1.3** 1.0***
Values are percentage except for the competence score variable. Source: Vignette survey. Observations from 395 providers. CIs reported in parentheses.
Asterisks represent statistically significant differences, with ***p<0.01, **p<0.05, *p<0.1.
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may incorrectly also report that they do not treat TB
when surveyed.
Provider knowledge: diagnostic questions, treatment and
referral
Table 2 shows the overall fraction of providers and frac-
tion by type of provider, who asked or performed key
diagnostic questions and examinations, made the right
diagnosis and provided the correct treatment. The most
common question asked by providers was duration of
fever (48.9%, 95% CI 43.8% to 53.9%). Only 32.2%
(95% CI 27.6% to 37.0%) of providers asked a key ques-
tion related to TB diagnosis about duration of cough
(30.9% (95% CI 24.9% to 36.9%) among unqualified,
relative to 37.1% (95% CI 22.7% to 51.5%) among
MBBS providers).
Few providers asked for results of common diagnostic
tests, though MBBS doctors were significantly more
likely to ask than other types of providers (table 2).
Overall, 31.9% of providers asked for a chest X-ray, 20%
asked for results from a Sputum test and 12.7% asked
for a Mantoux tuberculin skin test. (See vignette in
online supplementary appendix for positive results
reported for each of the tests.) While 57.1% of MBBS
providers asked for a chest X-ray, only 29.6% of unquali-
fied providers and 28.3% of BA/H/UMS providers did
so. Similarly, 16.9% of unqualified providers and 15.2%
of BA/H/UMS providers asked for sputum test results
relative to 54.3% of MBBS providers. The average
number of questions asked per provider was 2.66 and
the average number of examinations performed was
1.75, with no significant differences across provider
types.
Although almost all providers (92.4%) reported a
diagnosis on the vignette interview, unqualified provi-
ders and providers without MBBS degrees were more
likely to provide an incorrect diagnosis. Among the pro-
viders who gave a diagnosis, 94.1% of MBBS providers
gave a correct diagnosis, compared with 77.3% of BA/
H/UMS providers and 59.6% of unqualified providers.
Two-thirds of all providers (66.6%) prescribed treatment
on the vignette interviews, but only 14.4% of them pre-
scribed correct treatment. Among the ones who pre-
scribed any treatment, 55.2% of MBBS providers gave
the correct TB treatment. In comparison, only 24.3% of
BA/H/UMS providers and 16.2% of the unqualified
providers prescribed the correct treatment. When we
restricted the sample to providers who claimed to treat
TB in their practice, the share of providers who gave the
correct treatment was 19.5%, compared with 14.4%
among all providers. Almost all prescriptions recom-
mended also included additional medicines such as
multivitamin syrups, cough medicines and antipyretics.
Further, a substantial proportion of providers recom-
mended referring patients to larger facilities for treat-
ment (48.9%), with MBBS providers being statistically
more likely to refer relative to other types of providers.
The majority of providers (58.6%) prescribed other
drugs that did not include any medicines that are part
of the WHO multidrug treatment regimen for new TB
patients (see online supplementary appendix table A-1).
Further, only 31.9% of providers prescribed any combin-
ation of isoniazid (H) and rifampicin (R) and only
21.7% prescribed it for 6 months (180 days) or more
(per the WHO guidelines).
Knowledge scores and provider characteristics
Summarising the knowledge reflected in diagnostic
workup, diagnosis and treatment using IRT scores,
MBBS doctors showed significantly higher levels of TB
diagnostic and treatment knowledge than other provider
types (table 2 and figure 2) based on the Kolmogorov-
Smirnov (KS) tests of equality of distributions (p values
of 0.07 and 0.02 compared with BA/H/UMS and
unqualified providers, respectively). However, there is no
statistically significant difference in the distribution of
knowledge scores when restricted to the sample of provi-
ders who claim to treat TB (figure 3). The KS test of
equality of distributions is not significant when compar-
ing providers who claim to treat TB (p value of 0.34 and
0.36, respectively). The KS tests do not, however,
account for clustering, which would typically result in
higher p values by making estimates less precise.
We are interested in whether patients might be able to
choose providers with higher levels of TB diagnostic and
treatment knowledge by observing certain provider
characteristics. Both in the parsimonious model in
column 1 of table 3 as well as in column 2, which con-
trols for additional observable characteristics, age and
experience are not associated with knowledge scores.
Overall, the observable characteristics only explain
15.9% of the variation in knowledge measured on the
vignettes, suggesting that patients would have a very diffi-
cult time assessing the knowledge of providers by using
observable characteristics. Relative to providers with an
MBBS degree, those with BA/H/UMS qualifications as
well those with other (including non-medically trained)
qualifications have knowledge scores that are half an SD
lower (−0.55 for BA/H/UMS and −0.46 for other).
Hence, patients could in principle select to go to an
MBBS provider should one be available in their area if
they desired higher knowledge levels. However, as seen
in column 2, controlling for type of medical qualifica-
tions, practicing Homeopathic/Ayurvedic type of medi-
cine is associated with over a third of an SD (0.356)
higher knowledge score. In column 3, after controlling
for additional characteristics, including whether the pro-
vider reported treating TB, medical qualification is no
longer associated with knowledge score. Controlling for
medical qualification and self-reported TB treatment
and all other characteristics, practicing Ayurveda/
Homoeopathy/Unani continues to be significantly asso-
ciated with a 0.29 SD higher knowledge score and an
increase of about 10 working hours/week is associated
with a 0.07 SD increase in the knowledge score. Column
Mohanan M, et al. BMJ Glob Health 2016;1:e000155. doi:10.1136/bmjgh-2016-000155 7
BMJ Global Health
copyright.
 o
n
 July 20, 2020 at University of Edinburgh. Protected by
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2016-000155 on 16 December 2016. Downloaded from 
3 also indicates that the knowledge score among provi-
ders who claim to treat TB is about 0.46 SDs higher
compared with those who did not report this.
The regression results in online supplementary
appendix table A-2 show the analogous analyses from
table 3 restricted to the sample of providers who
claimed to treat TB. The results indicate that none of
the observable characteristics (such as medical qualifica-
tion, type of medicine practiced, average patient
caseload and infrastructure index) are significantly asso-
ciated with the knowledge score in this sample. These
results indicate that patients are likely to find it espe-
cially difficult to discern the knowledge of providers
among those who treat TB, and the dominant marker of
provider knowledge is whether they claim to treat TB or
not. Unfortunately, this marker might not be readily
observable to patients, especially ones who might not
know what their illness is.
Figure 3 Knowledge distribution by qualification, among providers who report treating tuberculosis.
Figure 2 Knowledge distribution by qualification.
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The results reported in table 4, where we conduct
OLS regressions of consultation fees on the set of
observable characteristics, further suggest that patients
might not be able to assess providers’ knowledge based
on observed prices in the market. In the parsimonious
model in column 1 of table 4, the coefficient on
medical qualification indicates that qualified providers
charge on average INR 24.1 more than BA/H/UMS pro-
viders and INR 46.9 more than unqualified providers.
Also a 1 SD increase in the knowledge score, controlling
for qualifications, age and experience, is associated with
a higher consultation fee of INR 3.4. Even after control-
ling for additional observable characteristics in columns
2 and 3, the coefficients on medical qualification and
the knowledge score remain significant and within a
similar range.
After controlling for the full set of observable
characteristics, including treating TB and provider
knowledge score, MBBS providers charge an average of
INR 28.1 more than BA/H/UMS providers and INR
47.9 more than unqualified providers. This suggests a
large premium charged by MBBS providers given that,
as we saw in table 2, there is no statistically significant
difference in the knowledge score of qualified versus
non-qualified providers once we control for treating TB.
The regression-adjusted difference in the knowledge
score between MBBS and BA/H/UMS providers is 0.202
(from table 3), which would only predict an increase of
INR 0.46 (0.202×2.282=0.76) instead of INR 28.1. If we
do not control for TB treatment, the predicted fee would
be only INR 2.40 higher (0.591×4.061). In a framework
where providers with higher knowledge could charge
higher fees, one possible explanation for our finding that
knowledge is not adequately priced could be due to sub-
stantial asymmetric information: patients cannot directly
assess providers’ knowledge and cannot infer it from out-
comes (either theirs or of other patients) due to varia-
tions in case-mix and infrequent experience. However,
another explanation might be that knowledge might be
only very loosely related to performance,13 which is what
ultimately matters for the patient.
Additionally, the regressions in column 3 of table 4
indicate that the practice of allopathic medicine is asso-
ciated with INR 12.97 higher consultation fee even after
controlling for qualifications. This probably explains why
so many BA/H/UMS providers end up adopting allo-
pathic therapeutic methods. Public health facilities
though, charge about INR 87.04 lower. Providers who
also sell medicines as part of their practice charge INR
7.18 lower than those who do not sell drugs on their
premises, presumably because profits from drug sales
could offset the fees.
In online supplementary appendix table A-3, which
shows the results from the same regressions as in table 4
Table 3 Knowledge score and providers characteristics
Variables Estimated effect (95% CI)
[1] [2] [3]
Age 0.03 (−0.04 to 0.09) 0.02 (−0.04 to 0.09) 0.02 (−0.05 to 0.08)
Age2 −0.00 (−0.00 to 0.00) −0.00 (−0.00 to 0.00) −0.00 (−0.00 to 0.00)
Experience (years) 0.00 (−0.02 to 0.02) −0.01 (−0.03 to 0.02) −0.01 (−0.03 to 0.01)
Medical qualification: BA/H/UMS −0.55 (−1.00 to −0.10) −0.59 (−1.08 to −0.10) −0.20 (−0.66 to 0.25)
Medical qualification: other −0.46 (−0.75 to −0.17) −0.39 (−0.77 to −0.00) 0.27 (−0.09 to 0.62)
Practice allopathy −0.01 (−0.35 to 0.33) −0.09 (−0.42 to 0.24)
Practice Ayur/Homoeo/Unani 0.36 (0.13 to 0.58) 0.29 (0.07 to 0.51)
Working hours (/week) 0.01 (−0.00 to 0.01) 0.01 (0.00 to 0.01)
Average patient caseload (day) 0.00 (−0.01 to 0.01) −0.00 (−0.01 to 0.01)
Run camps 0.14 (−0.24 to 0.52) −0.03 (−0.41 to 0.35)
Public health facility 0.35 (−0.13 to 0.83) 0.28 (−0.36 to 0.92)
Treat TB 0.46 (0.28 to 0.63)
Sell drug −0.20 (−0.40 to 0.01)
Infrastructure index 0.08 (0.01 to 0.15)
Consultation fee (Rs) 0.00 (−0.00 to 0.01)
Observations 395 395 395
R2 0.035 0.072 0.159
Columns 1–3 show OLS regression estimates of association between knowledge score and providers characteristics. The reference group for
Medical Qualification is MBBS. The first column includes variables related mainly with sociodemographic characteristics of the providers.
Column 2 includes variables related to effort/case load and type of facility. The last column includes variables related with the provider’s
capability (self-reported ability to treat TB), whether they sell drugs, reported fees and infrastructure index. The infrastructure index was
computed according to the following variables: electricity, power backup, number of consulting rooms, number of bed for day observation,
provision of tests, provision of X-rays and computer system. SEs in parentheses, clustered at the level of study cluster. Sources: Vignette survey
and Provider Questionnaire.
Mohanan M, et al. BMJ Glob Health 2016;1:e000155. doi:10.1136/bmjgh-2016-000155 9
BMJ Global Health
copyright.
 o
n
 July 20, 2020 at University of Edinburgh. Protected by
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2016-000155 on 16 December 2016. Downloaded from 
but run using a sample restricted to providers who treat
TB, the MBBS qualification is still significantly associated
with higher consultation fee. MBBS providers are likely
to charge INR 41.33 more than providers who are not
qualified, and INR 14.65 more than BA/H/UMS provi-
ders (although the latter is not statistically significant),
suggesting a substantial premium for the MBBS
qualification.
Correct diagnosis and treatment
Next, we turn to the relationship between provider
characteristics and making a correct diagnosis. As
columns 1 and 2 of table 5 show, unqualified providers
are significantly less likely to make a correct diagnosis
relative to MBBS providers (∼40%), and BA/H/UMS
providers do not show statistically significant differences
relative to MBBS providers. The knowledge score is sig-
nificantly and positively associated with making the
correct diagnosis. A 1 SD increase in the knowledge
score is associated with a 13 percentage point increase
(columns 1 and 2) in the probability of making a
correct diagnosis. The significant effects of medical
qualification and knowledge scores persist even after
controlling for other observable characteristics as seen
in column 3 of table 5.
We see similar results in online supplementary
appendix table A-4 when the regression is run on the
restricted sample of providers who stated that they treat
TB. Again, MBBS qualifications (relative to unqualified
providers) and knowledge scores are significantly posi-
tively associated with the probability of making a correct
diagnosis. In this restricted sample, we also see that the
probability of making a correct diagnosis is lower by 16.1
percentage points if a provider also sells drugs.
The parsimonious models in columns 1 and 2 in
table 6 show that providers with BA/H/UMS or no qua-
lifications are 20–30 percentage points less likely to pre-
scribe correct treatment relative to MBBS providers.
However, neither medical qualifications nor knowl-
edge scores are associated with the prescription of
correct treatment after controlling for the full set of
characteristics in column 3. Being a provider who treats
TB though is associated with a 13.6 percentage point
higher likelihood of prescribing the correct treatment.
We see similar results in online supplementary appendix
table A-5 when the regression is run on the sample
restricted to providers who state that they treat TB.
Referral
The likelihood of making a referral is significantly asso-
ciated with medical qualifications. Compared with those
with MBBS degrees, unqualified and BA/H/UMS provi-
ders are less likely to refer the TB case even after con-
trolling for all observable characteristics (column 3 of
Table 4 Consultation fee and providers characteristics
Variables Estimated effect (95% CI)
[1] [2] [3]
Age −0.73 (−2.93 to 1.47) −0.79 (−2.94 to 1.36) −0.83 (−2.91 to 1.26)
Age2 0.01 (−0.01 to 0.03) 0.01 (−0.01 to 0.03) 0.01 (−0.01 to 0.03)
Experience (years) 0.21 (−0.30 to 0.72) 0.14 (−0.28 to 0.56) 0.11 (−0.31 to 0.53)
Medical qualification: BA/H/U/MS −24.07 (−45.10 to −3.04) −34.00 (−53.00 to −15.00) −28.12 (−48.40 to −7.84)
Medical qualification: other −46.95 (−68.49 to −25.42) −58.38 (−78.42 to −38.33) −47.97 (−69.85 to −26.08)
Knowledge score 3.40 (1.42 to 5.39) 4.06 (1.97 to 6.15) 2.28 (−0.09 to 4.65)
Practice allopathy 14.71 (5.54 to 23.87) 12.97 (3.24 to 22.69)
Practice Ayur/Homoeo/Unani 0.33 (−6.33 to 6.99) −0.15 (−6.36 to 6.06)
Working hours (/week) −0.09 (−0.26 to 0.08) −0.07 (−0.24 to 0.10)
Average patient caseload (day) 0.35 (−0.08 to 0.77) 0.25 (−0.18 to 0.68)
Run camps 2.69 (−14.50 to 19.88) −0.97 (−18.65 to 16.72)
Public health facility −77.43 (−105.07 to −49.79) −87.04 (−113.93 to −60.15)
Treat TB 7.57 (0.98 to 14.16)
Sell drug −7.18 (−12.85 to −1.51)
Infrastructure index 2.42 (−0.68 to 5.52)
Observations 395 395 395
R2 0.245 0.363 0.396
Columns 1–3 show OLS regression estimates of association between consultation fee and providers characteristics. The reference group for
Medical Qualification is MBBS. The first column includes variables related mainly with sociodemographic characteristics of the providers.
Column 2 includes variables related with effort/case load and type of facility. The last column includes variables related with the provider’s
capability (self-reported ability to treat TB), whether they sell drugs, reported fees and infrastructure index. The infrastructure index was
computed according to the following variables: electricity, power backup, number of consulting rooms, number of bed for day observation,
provision of tests, provision of X-rays and computer system. SEs in parentheses, clustered at the level of study cluster. Sources: Vignette survey
and Provider Questionnaire.
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table 7). BA/H/UMS providers were 23.2 percentage
points less likely, and unqualified were 37.7 percentage
points less likely. While the knowledge score is signifi-
cantly and positively associated with referrals in parsimo-
nious models, it does not have a significant association
after controlling for the full set of observable
characteristics.
In online supplementary appendix table A-6, among
providers who claim to treat TB, unqualified providers
are significantly less (39.4 percentage points) likely to
make a referral. Providers who sell drugs also have 16.6
percentage points lower probability of making a referral.
DISCUSSION
In rural Bihar, as in much of other parts of India, TB
continues to be a major public health challenge. This
study provides further evidence that provider knowledge
of how to diagnose and treat a case of TB, as measured
by clinical vignettes, is low. This is the case for providers
who lack formal medical qualifications (who provide
most of the care in rural areas9) as well as those provi-
ders who have formal medical qualifications. Providers
ask few diagnostic questions (only 32% asked about dur-
ation of cough for TB, for example) and seldom seek
diagnostic test information (only 20% asked for sputum
test for TB). Provider performance on making a correct
diagnosis is inadequate but not as low as provider
performance on prescribing appropriate treatment.
Over 60% of providers arrived at the correct diagnosis;
but while more than 66% of providers prescribed a treat-
ment, only 21.7% of those were correct according to TB
treatment guidelines. Low rates of correct treatment
have significant implications for problems of TB drug
resistance.
The problem of poor TB diagnostic and treatment
accuracy is unlikely to be solved by shifting patients
towards MBBS providers in the area. While MBBS provi-
ders had higher average scores on diagnostic workup,
diagnostic accuracy and prescribing correct treatment
than other provider types, only 45.7% MBBS doctors still
only prescribed correct treatment. This pattern of MBBS
providers performing marginally better, but still at a
level that is unacceptably low is consistent with evidence
from recent studies in urban India using standardised
patients (SPs), which provide information on actual
practice.27 Second, after controlling for whether the pro-
vider offers treatment for TB, there are no statistically
significant differences in terms of provider knowledge
between MBBS and other types of difference. It is
important to bear in mind that 82.9% of MBBS provi-
ders offer treatment for TB, relative to 80.4% of BA/H/
UMS providers and 62.74% of providers with no formal
training. However, since the informal sector providers
are ubiquitous in the rural health landscape (almost 10
times as many as MBBS providers in our study sample),
Table 5 Correct diagnostic (if any)—marginal effects
Variables Estimated effect (95% CI)
[1] [2] [3]
Age 0.01 (−0.02 to 0.04) 0.01 (−0.01 to 0.04) 0.01 (−0.01 to 0.04)
Age2 −0.00 (−0.00 to 0.00) −0.00 (−0.00 to 0.00) −0.00 (−0.00 to 0.00)
Experience (years) 0.00 (−0.01 to 0.01) 0.00 (−0.01 to 0.01) 0.00 (−0.01 to 0.01)
Medical qualification: BA/H/UMS −0.19 (−0.46 to 0.07) −0.22 (−0.50 to 0.07) −0.12 (−0.39 to 0.15)
Medical qualification: other −0.40 (−0.63 to −0.17) −0.43 (−0.68 to −0.17) −0.27 (−0.53 to −0.00)
Knowledge score 0.13 (0.09 to 0.17) 0.13 (0.09 to 0.18) 0.11 (0.07 to 0.16)
Practice allopathy 0.08 (−0.09 to 0.25) 0.05 (−0.12 to 0.22)
Practice Ayurv/Homoeo/Unani −0.01 (−0.12 to 0.11) −0.02 (−0.13 to 0.10)
Working hours (/week) −0.00 (−0.00 to 0.00) −0.00 (−0.00 to 0.00)
Average patient caseload (day) −0.00 (−0.01 to 0.00) −0.00 (−0.01 to 0.00)
Run camps −0.07 (−0.24 to 0.11) −0.11 (−0.28 to 0.07)
Public health facility 0.10 (−0.30 to 0.50) 0.07 (−0.40 to 0.55)
Treat TB 0.08 (−0.02 to 0.18)
Sell drug −0.07 (−0.16 to 0.02)
Infrastructure index 0.02 (−0.02 to 0.07)
Consultation fee (Rs) 0.00 (−0.00 to 0.00)
Observations 365 365 365
Columns 1–3 show marginal effects of probit regression estimates of association between correct diagnosis variable for tuberculosis case and
providers characteristics. The reference group for medical qualification is MBBS. The first column includes variables related mainly with
sociodemographic characteristics of the providers. Column 2 includes variables related with effort/case load and type of facility. The last column
includes variables related with the provider’s capability (self-reported ability to treat TB), whether they sell drugs, reported fees and infrastructure
index. The infrastructure index was computed according to the following variables: electricity, power backup, number of consulting rooms,
number of bed for day observation, provision of tests, provision of X-rays and computer system. SEs in parentheses, clustered at the level of
study cluster. Sources: Vignette Survey and Provider Questionnaire.
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it is salient that after controlling for offering TB treat-
ment, these providers are comparable in knowledge and
correct treatment. A more disheartening view of this
finding is that providers with formal medical degrees do
not perform much better than those without formal
training on vignette-based assessments of knowledge of
diagnosing and treating TB. However, MBBS providers
are able to command a premium in terms of consulting
fees that is far higher than what a higher knowledge
score might indicate.
We also find that prescription of incorrect treat-
ments is related to the practice of selling drugs as
part of their medical practice. Lower rates of selling
drugs among those with formal qualifications reflect
the fact that in the informal health sector, there is a
missing market for consultations. Informal providers
typically tend to charge a fee for ‘treatment’ that
includes the drugs provided as opposed to a con-
sultant service, which ends with diagnosis and
prescription.
Our study faces limitations related to using data from
vignette-based interviews. The main limitation of the
vignette method is that it does not capture the actual
level of quality of care provided. As documented in
recent research on ‘know-do gaps’,7 28 the quality of
care provided to patients might in fact be considerably
lower than what is reported and measured on vignettes.
In fact, the know-do gap for TB care has been reported
in India, using data from SPs.28 While some of the mea-
sures we report (such as rates of sputum test recommen-
dations) are comparable with those reported from
previous research with SPs,28 we note that measures such
as correct diagnosis rates and appropriate referral are
higher with data from vignettes. As a result, the (low)
level of knowledge that we report represents the upper
bound of what providers might actually provide. Further,
our estimates of provider knowledge in rural Bihar are
representative of similar socioeconomic and geographic
areas in developing countries like India, but might not
be widely generalisable.
Low levels of provider knowledge of TB diagnosis and
treatment could not only hamstring ongoing efforts to
control TB, but also make it worse by contributing to
multidrug resistance.29 Recent experimental evidence
on improvement on provider knowledge and adherence
to protocol from intensive training programmes offered
to informal sector providers in West Bengal provides a
potential solution to addressing this challenge.30
Medical organisations in India have typically opposed
proposals to offer training or improving capacity of
informal sector providers, advocating instead for policies
to increase MBBS trained providers. The challenge,
however, is that trained MBBS/MD graduates are
unlikely to choose to practice and live in rural areas.
While the number of medical training institutions in
India have increased dramatically in the past few
Table 6 Correct treatment (if any)—marginal effects
Estimated effect (95% CI)
Variables [1] [2] [3]
Age −0.00 (−0.04 to 0.04) −0.00 (−0.04 to 0.03) −0.00 (−0.04 to 0.03)
Age2 −0.00 (−0.00 to 0.00) 0.00 (−0.00 to 0.00) 0.00 (−0.00 to 0.00)
Experience (years) 0.00 (−0.01 to 0.01) 0.00 (−0.01 to 0.01) −0.00 (−0.01 to 0.01)
Medical qualification: BA/H/UMS −0.20 (−0.39 to −0.02) −0.20 (−0.41 to 0.00) −0.14 (−0.34 to 0.07)
Medical qualification: other −0.30 (−0.44 to −0.16) −0.29 (−0.46 to −0.13) −0.11 (−0.31 to 0.10)
Knowledge score 0.04 (−0.02 to 0.10) 0.04 (−0.02 to 0.11) 0.02 (−0.04 to 0.08)
Practice allopathy 0.23 (0.04 to 0.42) 0.20 (0.02 to 0.38)
Practice Ayurv/Homoeo/Unani 0.01 (−0.11 to 0.12) 0.00 (−0.11 to 0.11)
Working hours (/week) −0.00 (−0.00 to 0.00) −0.00 (−0.00 to 0.00)
Average patient caseload (day) −0.00 (−0.01 to 0.00) −0.00 (−0.01 to 0.00)
Run camps 0.08 (−0.08 to 0.23) 0.04 (−0.11 to 0.19)
Public health facility −0.10 (−0.38 to 0.18) 0.01 (−0.38 to 0.40)
Treat TB 0.14 (0.03 to 0.24)
Sell drug −0.03 (−0.12 to 0.07)
Infrastructure index 0.01 (−0.03 to 0.05)
Consultation fee (Rs) 0.00 (0.00 to 0.00)
Observations 263 263 263
Columns 1–3 show marginal effect of probit regression estimates of association between correct diagnosis variable for tuberculosis case and
providers characteristics. The reference group for medical qualification is MBBS. The first column includes variables related mainly with
sociodemographic characteristics of the providers. Column 2 includes variables related with effort/case load and type of facility. The last column
includes variables related with the provider’s capability (self-reported ability to treat TB), whether they sell drugs, reported fees and infrastructure
index. The infrastructure index was computed according to the following variables: electricity, power backup, number of consulting rooms,
number of bed for day observation, provision of tests, provision of X-rays and computer system. SEs in parentheses, clustered at the level of
study cluster. Sources: Vignette Survey and Provider Questionnaire.
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decades,23 India’s rural population continues to receive
healthcare primarily from informal sector providers
(Das et al. 2015. Forthcoming). Policymakers in India,
and elsewhere, might want to prioritise strategies such as
training, incentives, task shifting and regulation to
improve knowledge and performance of existing provi-
ders in the healthcare system.
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